Ben is a PhD molecular and cell biologist who has experience both within the pharmaceutical industry and within the publishing industry that serves it. For several years, he worked as an Editor of a publication that identified the latest discoveries in science which support drug discovery. This provided him with a broad background in almost all therapeutic areas relevant to the pharmaceutical industry. Prior to this, he has worked as a research scientist for AstraZeneca and The University of Glasgow. As the Medical Director at Random42, Ben writes scripts and provides continual scientific support for all projects, ensuring that they are scientifically correct and accurate.